Similarities & Differences
HaidiC_03
PosterBoard1.pptxExamining SSRI vs. Benzodiazepine Treatment for Social Anxiety in University Students with Substance Dependence
Chancy, Haidi
Datis, Gerline
Martinez, Claudia
Pereira, Sergio
Williams, Shawnette
Examining SSRI vs. Benzodiazepine Treatment for Social Anxiety in University Students with Substance Dependence
Background
Background and Significance:
Social anxiety significantly hampers students' academic and social engagement, potentially leading to substance dependence as a coping mechanism. The study recognizes the detrimental effects of untreated social anxiety and substance dependence on academic achievements and long-term success
Methods & Data
Methods & Data:
A systematic literature review was conducted using Cochrane PsycINFO and PubMed, covering research studies published between 2017 and 2023. The selected studies focused on the use of SSRIs and Benzodiazepines in treating social anxiety in university students with substance dependence.
Rationale and Background
Purpose or Rationale:
This poster explores the efficacy and safety of SSRIs and Benzodiazepines in treating social anxiety in university students with substance dependence. The study addresses the significance of identifying appropriate long-term treatments to alleviate the impact of social anxiety on academic performance and overall well-being.
Conclusions and Implications
The findings of the systematic review emphasize the effectiveness of SSRIs and Benzodiazepines in treating social anxiety in university students with substance dependence.
The conclusion suggests that SSRIs, with their superior effectiveness and safety profile, are a preferred choice. However, the study underscores the importance of cautious prescribing due to the potential risk of misuse.
Model Graphic
Outcomes
Major Outcomes:
The literature review identified SSRIs and Benzodiazepines as the preferred treatments for university students with social anxiety and substance dependence. SSRIs, in particular, were found to be more effective in promoting remission and reducing symptoms, fostering students' confidence in social activities. However, the study also highlights the need for careful consideration due to the risk of misuse.
Peer-reviewed Journal articles
Gomez, A., & Hofmann, S. (2020, May 26). SSRIs and Benzodiazepines for General Anxiety Disorders (GAD). Adaa.org. https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/ssris-and-benzodiazepines-general-anxiety
Gosmann, N. P., Costa, M. de A., Jaeger, M. de B., Motta, L. S., Frozi, J., Spanemberg, L., Manfro, G. G., Cuijpers, P., Pine, D. S., & Salum, G. A. (2021). Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis. PLOS Medicine, 18(6), e1003664. https://doi.org/10.1371/journal.pmed.1003664
Kushner, M. G., Abrams, K., & Borchardt, C. (2020). Anxiety and substance use disorders: A review. Comprehensive Psychiatry.
Leigh, E., & Clark, D. M. (2018). Understanding Social Anxiety Disorder in Adolescents and Improving Treatment Outcomes: Applying the Cognitive Model of Clark and Wells (1995). Clinical Child and Family Psychology Review, 21(3), 388–414. https://doi.org/10.1007/s10567-018-0258-5
Nguyen, D. T., Wright, E. P., Dedding, C., Pham, T. T., & Bunders, J. (2019). Low Self-Esteem and Its Association With Anxiety, Depression, and Suicidal Ideation in Vietnamese Secondary School Students: A Cross-Sectional Study. Frontiers in Psychiatry, 10(698). https://doi.org/10.3389/fpsyt.2019.00698
Schlauch, R. C., & Crane, C. (2021). Anxiety and substance use disorders: A narrative review. Psychological Reports.
